Literature DB >> 32362837

Optimized and Personalized Phlebotomy Schedules for Patients Suffering From Polycythemia Vera.

Patrick Lilienthal1, Manuel Tetschke1, Enrico Schalk2, Thomas Fischer2, Sebastian Sager1.   

Abstract

Polycythemia vera (PV) is a slow-growing type of blood cancer, where the production of red blood cells (RBCs) increase considerably. The principal treatment for targeting the symptoms of PV is bloodletting (phlebotomy) at regular intervals based on data derived from blood counts and physician assessments based on experience. Model-based decision support can help to identify optimal and individualized phlebotomy schedules to improve the treatment success and reduce the number of phlebotomies and thus negative side effects of the therapy. We present an extension of a simple compartment model of the production of RBCs in adults to capture patients suffering from PV. We analyze the model's properties to show the plausibility of its assumptions. We complement this with numerical results using exemplary PV patient data. The model is then used to simulate the dynamics of the disease and to compute optimal treatment plans. We discuss heuristics and solution approaches for different settings, which include constraints arising in real-world applications, where the scheduling of phlebotomies depends on appointments between patients and treating physicians. We expect that this research can support personalized clinical decisions in cases of PV.
Copyright © 2020 Lilienthal, Tetschke, Schalk, Fischer and Sager.

Entities:  

Keywords:  cancer; decision support; mixed-integer non-linear optimization; modeling; numerical simulation; optimal control; polycythemia vera; therapy scheduling

Year:  2020        PMID: 32362837      PMCID: PMC7180210          DOI: 10.3389/fphys.2020.00328

Source DB:  PubMed          Journal:  Front Physiol        ISSN: 1664-042X            Impact factor:   4.566


  27 in total

Review 1.  Techniques used for the determination of blood volume.

Authors:  Andrew C Ertl; André Diedrich; Satish R Raj
Journal:  Am J Med Sci       Date:  2007-07       Impact factor: 2.378

2.  The life span of the red blood cell in chronic leukemia and polycythemia.

Authors:  N I BERLIN; J H LAWRENCE; H C LEE
Journal:  Science       Date:  1951-10-12       Impact factor: 47.728

3.  Vascular and neoplastic risk in a large cohort of patients with polycythemia vera.

Authors:  Roberto Marchioli; Guido Finazzi; Raffaele Landolfi; Jack Kutti; Heinz Gisslinger; Carlo Patrono; Raphael Marilus; Ana Villegas; Gianni Tognoni; Tiziano Barbui
Journal:  J Clin Oncol       Date:  2005-02-14       Impact factor: 44.544

4.  Recovery of hemoglobin mass after blood donation.

Authors:  Torben Pottgiesser; Wolfgang Specker; Markus Umhau; Hans-Hermann Dickhuth; Kai Roecker; Yorck O Schumacher
Journal:  Transfusion       Date:  2008-05-02       Impact factor: 3.157

5.  Life expectancy of patients with chronic nonleukemic myeloproliferative disorders.

Authors:  C Rozman; M Giralt; E Feliu; D Rubio; M T Cortés
Journal:  Cancer       Date:  1991-05-15       Impact factor: 6.860

Review 6.  Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both.

Authors:  S Koschmieder; T I Mughal; H C Hasselbalch; G Barosi; P Valent; J-J Kiladjian; G Jeryczynski; H Gisslinger; J S Jutzi; H L Pahl; R Hehlmann; A Maria Vannucchi; F Cervantes; R T Silver; T Barbui
Journal:  Leukemia       Date:  2016-02-08       Impact factor: 11.528

Review 7.  How I treat patients with polycythemia vera.

Authors:  Guido Finazzi; Tiziano Barbui
Journal:  Blood       Date:  2007-01-30       Impact factor: 22.113

8.  Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases.

Authors:  Ruben A Mesa; Chin-Yang Li; Rhett P Ketterling; Georgene S Schroeder; Ryan A Knudson; Ayalew Tefferi
Journal:  Blood       Date:  2004-09-23       Impact factor: 22.113

9.  Polycythemia vera: the natural history of 1213 patients followed for 20 years. Gruppo Italiano Studio Policitemia.

Authors: 
Journal:  Ann Intern Med       Date:  1995-11-01       Impact factor: 25.391

10.  Hemoglobin concentration, total hemoglobin mass and plasma volume in patients: implications for anemia.

Authors:  James M Otto; James O M Plumb; Eleri Clissold; Shriya B Kumar; Denis J Wakeham; Walter Schmidt; Michael P W Grocott; Toby Richards; Hugh E Montgomery
Journal:  Haematologica       Date:  2017-06-08       Impact factor: 9.941

View more
  1 in total

1.  Expert-enhanced machine learning for cardiac arrhythmia classification.

Authors:  Sebastian Sager; Felix Bernhardt; Florian Kehrle; Maximilian Merkert; Andreas Potschka; Benjamin Meder; Hugo Katus; Eberhard Scholz
Journal:  PLoS One       Date:  2021-12-23       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.